$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Medical drugs
Medical drugs
Medical drugs-Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Summary of the differences in efficacy between ribociclib (Calilon) and palbocicillin in the combined or comparative treatment of breast cancer
2026-02-01 22:25:32
Check Details
Is cemiplimab an immune drug or a targeted drug and an in-depth analysis of its PD-1 inhibition mechanism
2026-02-01 22:25:32
Check Details
Which class of drugs does Daprodustat belong to and its position and characteristics among HIF-PH inhibitors?
2026-02-01 22:25:32
Check Details
Is durvalumab (durvalumab) an immunological drug or a targeted drug and analysis of its mechanism
2026-02-01 22:25:32
Check Details
Which company is developing and producing Zolbetuximab and its global launch and supply status?
2026-02-01 22:25:32
Check Details
Key contents of the official instruction manual of EIKANCE 0.01% Atropine Sulfate Eye Drops, including usage, dosage and contraindications
2026-02-01 22:25:32
Check Details
Telisotuzumab-EMRELIS complete Chinese instruction manual, including indications, usage and precautions
2026-02-01 22:25:32
Check Details
Analysis of tovorafenib usage and dosage, clinical medication regimens and precautions for different patients
2026-02-01 22:25:32
Check Details
Is vorasidenib-VORANIGO effective against Candida glabrata and analysis of clinical efficacy and research results
2026-02-01 22:25:32
Check Details
How many years of Zongatinib (Zongatinib) is generally taken and the safety of long-term use
2026-02-01 22:25:32
Check Details
Analysis of the side effects of vosoritide and tips on common adverse reactions, long-term safety and medication risks
2026-02-01 22:25:32
Check Details
Analysis of whether methylcobalamin injection (Rozebalamin) is effective in treating tinnitus and improving auditory nerve damage
2026-02-01 22:25:32
Check Details
1
2
...
2413
2414
2415
2416
2417
2418
2419
...
2439
2440
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Global Oncology Update: Breakthroughs in Advanced Cancer Survival and Novel Therapies
2
Phase 1 Study Progress of Ceralasertib in Combination with Durvalumab for Advanced NSCLC and HNSCC
3
Global Breakthroughs in Cancer Drugs and Advanced Treatment Technologies
4
ROS and Cancer: The Potential of Natural Antioxidants
5
SKYSCRAPER-02C Study: New Hope for Extensive-Stage Small Cell Lung Cancer Treatment
6
LPCAT3: The Key Player in MASH Progression to Hepatocellular Carcinoma
7
Breztri Aerosphere Approved by US FDA for Maintenance Treatment of Asthma in Patients Aged 12 Years and Older
8
Datopotamab Deruxtecan as First-Line Treatment for Advanced Triple-Negative Breast Cancer: Full Interpretation of the Phase III TROPION-Breast02 Trial
9
Olaparib Plus Pembrolizumab Maintenance Therapy for Metastatic Pancreatic Cancer: Findings from the POLAR Phase II Basket Trial
10
From Causes to Treatments—Exploring Medical Breakthroughs
11
IRX4 Transcription Factor: New Research Insights on Colorectal Cancer Treatment Targets
12
New Research Progress on Clonal Hematopoiesis of Indeterminate Potential (CHIP) and Tumor Relationship